Cellectis (CLLS) Change in Cash (2015 - 2026)
Cellectis (CLLS) recorded quarterly Change in Cash of -$26.5 million in Q1 2026, down 433.06% quarter-over-quarter from $7.9 million in Q4 2025, and down 55.48% on a YoY basis from -$59.5 million in Q1 2025.
Cellectis (CLLS) Change in Cash (2015 - 2026) Analysis & Trends
Cellectis' Change in Cash history runs 12 years deep, the most recent figure standing at -$26.5 million for Q1 2026.
- In Q1 2026, Change in Cash fell 55.48% year-over-year to -$26.5 million; the TTM figure through Mar 2026 stood at -$95.1 million (down 1757.56% YoY), while the FY2025 annual figure was -$85.6 million, down 1021.43% from the prior year.
- Change in Cash was -$26.5 million for Q1 2026 at Cellectis, down from $7.9 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $67.6 million in Q4 2023 to a low of -$67.3 million in Q2 2025.
- Historically, Change in Cash has averaged -$8.8 million across 5 years, with a median of -$13.5 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Cash soared 2495.06% in 2024, then sank 377.38% in 2025.
- A 5-year view of Change in Cash shows it stood at -$6.4 million in 2022, then soared by 1152.81% to $67.6 million in 2023, then plunged by 120.37% to -$13.8 million in 2024, then soared by 157.68% to $7.9 million in 2025, then tumbled by 433.06% to -$26.5 million in 2026.
- The last three Change in Cash figures came in at -$26.5 million (Q1 2026), $7.9 million (Q4 2025), and -$9.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | -26.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.48 Mn |
| Dec 31, 2025 | 7.95 Mn |
| Sep 30, 2025 | -9.27 Mn |
| Jun 30, 2025 | -67.30 Mn |
| Mar 31, 2025 | -17.03 Mn |
| Dec 31, 2024 | -13.78 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Jun 30, 2024 | 24.26 Mn |
| Mar 31, 2024 | -13.47 Mn |
| Dec 31, 2023 | 67.64 Mn |
| Sep 30, 2023 | -15.71 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -8.32 Mn |
| Dec 31, 2022 | -6.43 Mn |
| Sep 30, 2022 | -30.22 Mn |
| Jun 30, 2022 | -22.50 Mn |
| Mar 31, 2022 | -29.92 Mn |
| Dec 31, 2021 | -22.71 Mn |
| Sep 30, 2021 | -36.57 Mn |
| Jun 30, 2021 | 40.35 Mn |